Literature DB >> 7197334

Effects of dopaminergic drugs on phencyclidine-induced behavior in the rat.

S Castellani, P M Adams.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7197334     DOI: 10.1016/0028-3908(81)90011-3

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


× No keyword cloud information.
  7 in total

1.  Phencyclidine-induced increases in striatal neuron firing in behaving rats: reversal by haloperidol and clozapine.

Authors:  I M White; G S Flory; K C Hooper; J Speciale; D A Banks; G V Rebec
Journal:  J Neural Transm Gen Sect       Date:  1995

2.  Blockade of phencyclidine-induced effects by a nitric oxide donor.

Authors:  M Bujas-Bobanovic; D C Bird; H A Robertson; S M Dursun
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

Review 3.  Glutamate receptor genes: susceptibility factors in schizophrenia and depressive disorders?

Authors:  Hans H Schiffer
Journal:  Mol Neurobiol       Date:  2002-04       Impact factor: 5.590

4.  Effects of phencyclidine, haloperidol, and naloxone on fixed-interval performance in rats.

Authors:  G C Wagner; D B Masters; A Tomie
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

5.  Phencyclidine-induced locomotor activity in the rat is blocked by 6-hydroxydopamine lesion of the nucleus accumbens: comparisons to other psychomotor stimulants.

Authors:  E D French; G Vantini
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

6.  Effects of naloxone, metenkephalin, and morphine on phencyclidine-induced behavior in the rat.

Authors:  S Castellani; A J Giannini; P M Adams
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

7.  Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine.

Authors:  B Adams; B Moghaddam
Journal:  J Neurosci       Date:  1998-07-15       Impact factor: 6.167

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.